Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Regenerative Medicine Market to Reach $5.5 Billion by 2025: Regional Estimates & Trend Analysis, by Product and Therapeutic Category - Research and Markets

Research and Markets
Posted on: 18 Aug 17

The "Regenerative Medicine Market, 2014 - 2025" report has been added to Research and Markets' offering.

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to this new report. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Companies Mentioned

  • Integra LifeSciences Corporation
  • Astellas Pharma Inc.
  • Ocata Therapeutics, Inc.
  • Corline Biomedical AB
  • Cook Biotech
  • Bayer BV
  • BlueRock Therapeutics
  • AstraZeneca
  • MedImmune
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Sigma-Aldrich Co. LLC
  • Merck Millipore
  • Abbott
  • St. Jude Medical, Inc.
  • Vericel Corporation
  • Novartis AG
  • Alcon
  • GlaxoSmithKline plc.
  • (15+ Others)

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Regenerative Medicine Market Variables, Trends & Scope

4. Regenerative Medicine Market: Product Type Estimates & Trend Analysis

5. Regenerative Medicine Market: Therapeutic Category Estimates & Trend Analysis

6. Regenerative Medicine Market: Regional Estimates & Trend Analysis, by Product And Therapeutic Category

7. Competitive Landscape

For more information about this report visit

View source version on

Business Wire

Last updated on: 18/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.